Supernus Pharmaceuticals | SUPN - Trade Creditors


Supernus Pharmaceuticals reported $108.61M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Abbott USD 4.12B 183M Sep/2025
ANI Pharmaceuticals USD 69.8M 15.23M Sep/2025
Aurora Cannabis CAD 49.34M 31.94M Sep/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Canopy Growth CAD 18.14M 5.94M Sep/2025
Corcept Therapeutics USD 34.45M 10.92M Sep/2025
Eisai JPY 80.73B 2.26B Sep/2025
Eli Lilly USD 4.26B 186.5M Sep/2025
Novo Nordisk DKK 19.76B 4.15B Dec/2025
Pacira USD 17.69M 12.44M Sep/2025
Perrigo USD 469.7M 19.3M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Supernus Pharmaceuticals USD 108.61M 100.4M Sep/2025
United Therapeutics USD 468M 36M Sep/2025
Xeris Pharmaceuticals USD 6.53M 2.93M Sep/2025